4DMedical Ltd (4DX) Price & Analysis

Q: What was 4DMedical Ltd’s price range in the past 12 months?

4DMedical Ltd lowest share price was AU$0.23 and its highest was AU$2.55 in the past 12 months.

Q: What is 4DMedical Ltd’s market cap?

4DMedical Ltd’s market cap is AU$830.45M.

Q: When is 4DMedical Ltd’s upcoming earnings report date?

4DMedical Ltd’s upcoming earnings report date is Mar 04, 2026 which is in 82 days.

Q: How were 4DMedical Ltd’s earnings last quarter?

4DMedical Ltd released its earnings results on Aug 28, 2025. The company reported -AU$0.109 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.109.

Q: Is 4DMedical Ltd overvalued?

According to Wall Street analysts 4DMedical Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Q: Does 4DMedical Ltd pay dividends?

4DMedical Ltd does not currently pay dividends.

Q: What is 4DMedical Ltd’s EPS estimate?

4DMedical Ltd’s EPS estimate is -0.04.

Q: How many shares outstanding does 4DMedical Ltd have?

4DMedical Ltd has 515,808,500 shares outstanding.

Q: What happened to 4DMedical Ltd’s price movement after its last earnings report?

4DMedical Ltd reported an EPS of -AU$0.109 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 18.75%.

Q: Which hedge fund is a major shareholder of 4DMedical Ltd?

Currently, no hedge funds are holding shares in AU:4DX

Compare

112 Followers

4DX Stock Chart & Stats

AU$2.12

<AU$0.01(1.02%)

At close: Jan 09 4:00 PM EST

AU$2.12

<AU$0.01(1.02%)

Day’s Range― - ―

52-Week RangeAU$0.23 - AU$2.55

Previous CloseN/A

Volume497.15K

Average Volume (3M)10.77M

Market Cap

AU$830.45M

Enterprise ValueAU$104.24M

Total Cash (Recent Filing)AU$6.88M

Total Debt (Recent Filing)AU$4.31M

Price to Earnings (P/E)―

Beta1.15

Next Earnings

Mar 04, 2026

EPS Estimate

-0.04

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.11

Shares Outstanding515,808,500

10 Day Avg. Volume5,850,211

30 Day Avg. Volume10,774,582

Financial Highlights & Ratios

PEG Ratio-0.06

Price to Book (P/B)0.80

Price to Sales (P/S)8.81

P/FCF Ratio-1.49

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

AU$2.50

Price Target Upside17.92% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

4DMedical Ltd News

4DMedical Secures $30.2 Million Funding to Propel CT:VQ™ Commercialization

4DMedical Ltd ( ($AU:4DX) ) has provided an update. 4DMedical Limited has secured $30.2 million in funding through...

23h ago

4DX

4DMedical Expands U.S. Presence with Key Partnerships

The latest announcement is out from 4DMedical Ltd ( ($AU:4DX) ). 4DMedical Limited has announced that the University...

3d ago

4DX

4DMedical Expands Distribution of CT:VQ™ with Philips Deal

4DMedical Ltd ( ($AU:4DX) ) has shared an update. 4DMedical Limited has announced a significant expansion of its...

10d ago

4DX

4DMedical Announces Expiry of Listed Options by Year-End

4DMedical Ltd ( ($AU:4DX) ) just unveiled an announcement. 4DMedical Limited announced the expiry of its listed options,...

12d ago

4DX

4DMedical Ltd Announces Quotation of New Securities on ASX

4DMedical Ltd ( ($AU:4DX) ) has provided an announcement. 4DMedical Ltd has announced the quotation of 53,333 fully...

17d ago

4DX

4DMedical Ltd Expands Market Presence with New Securities Quotation

The latest update is out from 4DMedical Ltd ( ($AU:4DX) ). 4DMedical Ltd announced the quotation of additional...

26d ago

4DX

4DMedical Responds to ASX Query on Intangible Asset Impairment

4DMedical Ltd ( ($AU:4DX) ) has provided an update. 4DMedical Ltd addressed a query from the ASX regarding...

1M ago

4DX

4DMedical Secures Strong Shareholder Support at AGM

4DMedical Ltd ( ($AU:4DX) ) has shared an announcement. 4DMedical Limited announced the successful passage of all resolutions...

1M ago

4DX

4DMedical’s CT:VQ™ Gains FDA Clearance, Expands Global Reach

4DMedical Ltd ( ($AU:4DX) ) has shared an update. 4DMedical Limited has achieved a major milestone with the...

1M ago

4DX

4DMedical Showcases Strong Growth and Strategic Advances at 2025 AGM

4DMedical Ltd ( ($AU:4DX) ) has issued an update. 4DMedical Limited presented its achievements and future plans at...

1M ago

4DX

4DX FAQ

What was 4DMedical Ltd’s price range in the past 12 months?

4DMedical Ltd lowest share price was AU$0.23 and its highest was AU$2.55 in the past 12 months.

What is 4DMedical Ltd’s market cap?

4DMedical Ltd’s market cap is AU$830.45M.

When is 4DMedical Ltd’s upcoming earnings report date?

4DMedical Ltd’s upcoming earnings report date is Mar 04, 2026 which is in 82 days.

How were 4DMedical Ltd’s earnings last quarter?

4DMedical Ltd released its earnings results on Aug 28, 2025. The company reported -AU$0.109 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.109.

Is 4DMedical Ltd overvalued?

According to Wall Street analysts 4DMedical Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does 4DMedical Ltd pay dividends?

4DMedical Ltd does not currently pay dividends.

What is 4DMedical Ltd’s EPS estimate?

4DMedical Ltd’s EPS estimate is -0.04.

How many shares outstanding does 4DMedical Ltd have?

4DMedical Ltd has 515,808,500 shares outstanding.

What happened to 4DMedical Ltd’s price movement after its last earnings report?

4DMedical Ltd reported an EPS of -AU$0.109 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 18.75%.

Which hedge fund is a major shareholder of 4DMedical Ltd?

Currently, no hedge funds are holding shares in AU:4DX

4DMedical Ltd Stock Smart Score

Outperform

Fundamentals

Return on Equity

-44.49%

Trailing 12-Months

Asset Growth

-21.00%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

4DMedical Ltd

4DMedical Ltd (4DX) is a medical technology company specializing in advanced imaging solutions for lung health. Utilizing its proprietary 4D lung imaging technology, 4DX provides healthcare professionals with detailed insights into lung function and pathology. The company operates primarily in the healthcare sector, focusing on improving the diagnosis and management of respiratory diseases, particularly for conditions like asthma and chronic obstructive pulmonary disease (COPD). 4DX's core products include its 4D lung imaging systems, which are designed to enhance patient outcomes through precise diagnostic capabilities.

4DMedical Ltd (4DX) Earnings & Revenues

Historic Earnings Reports

4DX Stock 12 Month Forecast

Average Price Target

AU$2.50

▲(17.92% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"AU$0","1":"AU$1","2":"AU$2","3":"AU$3","-1":"-AU$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$2.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$2.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$2.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0,1,2,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.74,1.7984615384615386,1.856923076923077,1.9153846153846155,1.9738461538461538,2.0323076923076924,2.0907692307692307,2.149230769230769,2.207692307692308,2.266153846153846,2.3246153846153845,2.3830769230769233,2.4415384615384617,{"y":2.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.74,1.7984615384615386,1.856923076923077,1.9153846153846155,1.9738461538461538,2.0323076923076924,2.0907692307692307,2.149230769230769,2.207692307692308,2.266153846153846,2.3246153846153845,2.3830769230769233,2.4415384615384617,{"y":2.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.74,1.7984615384615386,1.856923076923077,1.9153846153846155,1.9738461538461538,2.0323076923076924,2.0907692307692307,2.149230769230769,2.207692307692308,2.266153846153846,2.3246153846153845,2.3830769230769233,2.4415384615384617,{"y":2.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.62,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.44,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.48,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.54,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.26,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.3,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.32,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.24,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.3,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.78,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.26,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.74,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.74,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >